TENX Awaits Data In Jan, GBIM Hit Hard, FDA Says No To SPPI

Spectrum Pharmaceuticals Inc. (SPPI) on Friday revealed that its New Drug Application for Qapzola for immediate intravesical instillation post-transurethral resection of bladder tumors has been turned down by the FDA.

from RTT - Biotech http://ift.tt/2fvXT3K
via IFTTT